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A previous study conducted at the same institution, with a
patient population of 77, concluded that high dose dexme-
detomidine can be successfully used for MRI sedation in
children, with 29% of patients requiring additional agents
for optimal sedation [19]. In our study, over the course
of five years, the patient cohort was larger (544 patients)
and included the previously reported 77-patient cohort. This
larger patient cohort analysis validated previously reported
data: 100% success of the existing sedation protocol, rounded
up from 99.8% acknowledging one patient failure, with the
adjunctive sedative agents used on 21.5% of cases.
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